Literature DB >> 7389749

Plasma levels and urinary excretion of orally administered propantheline bromide in man.

C W Vose, P M Stevens, N J Haskins, K A Waddell, A J Hawkins, D A Rose, G L Evans, R F Palmer, V Diaz, J Garza, O Martin, H Rudel.   

Abstract

After a single oral dose of 30 or 60 mg of propantheline bromide peak plasma levels of the drug were reached within 2 h in six healthy men. Mean peak plasma concentrations were 20.6 and 53.1 ng/ml after 30 mg and 60 mg respectively. The mean apparent absorption and elimination half-lives after 30 mg dose were 0.22 and 1.57 h respectively, and similar half-lives were found at the higher dose level. There was a dose related change in plasma levels and AUCinfinity of the drug, and some 3% to 4% of the administered dose of propantheline bromide was excreted unchanged in urine at each dose level. Comparison of the plasma levels and urinary excretion of the drug with those seen after i.v. administration in an earlier study indicated an apparently low systemic availability of orally administered propantheline bromide. There was tentative evidence of a qualitative relationship between the oral dose administered, plasma concentrations and the effects of propantheline bromide on salivary excretion.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389749     DOI: 10.1007/BF03189440

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  7 in total

1.  Biopharmaceutic influences on the anticholinergic effects of propantheline.

Authors:  M Gibaldi; B Grundhofer
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  The measurements of propantheline ion in biological fluids after administering propantheline bromide to man.

Authors:  G C Ford; S J Grigson; N J Haskins; R F Palmer; M Prout; C W Vose
Journal:  Biomed Mass Spectrom       Date:  1977-04

3.  On the metabolism of propantheline in man.

Authors:  B Beermann; K Hellström; A Rosèn
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

4.  Histochemical localization of gastric and small bowel mucosal enzymes of man, monkey, and chimpanzee.

Authors:  M H Floch; S Van Noorden; H M Spiro
Journal:  Gastroenterology       Date:  1967-02       Impact factor: 22.682

5.  Comparative studies on intramuscular and oral effective doses of some anticholinergic drugs.

Authors:  J Möller; A Rosén
Journal:  Acta Med Scand       Date:  1968-09

6.  Pharmacokinetics of propantheline bromide in normal man.

Authors:  C W Vose; G C Ford; S J Grigson; N J Haskins; M Prout; P M Stevens; D A Rose; R F Palmer; H Rudel
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

7.  Identification of some urinary metabolites of propantheline bromide in man.

Authors:  C W Vose; M Prout; N J Haskins; C Ford; R F Palmer; M J Tidd
Journal:  Xenobiotica       Date:  1978-12       Impact factor: 1.908

  7 in total
  3 in total

1.  Food reduces the oral bioavailability of propantheline bromide in healthy subjects.

Authors:  D K Moses; B G Charles; P J Ravenscroft; I M Whyte
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

2.  Propantheline bromide plasma level, urinary excretion and pharmacological data in a comparison of the bioavailability of three oral formulations of Pro-Banthine.

Authors:  G V Rigby; C W Vose; N J Haskins; E F Allan; I R Harrison; J R Shelton; R D Brownsill; R M Perkins; G C Ford; A J Hawkins
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Jul-Sep       Impact factor: 2.441

Review 3.  Clinical pharmacokinetics of drugs used to treat urge incontinence.

Authors:  David R P Guay
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.